TLR4-mediated IRAK1 activation induces TNF-α expression via JNK-dependent NF-κB activation in human bronchial epithelial cells

European Journal of Inflammation

Volumn 13, Issue 3, 2015, Pages 183-195

  Park, Sae Hoon ^a   Choi, Hye Jin ^b   Lee, So Young ^b   Han, Joong Soo ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

Author keywords

IRAK1; JNK; NF B; TLR4; TNF a

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 84949236678     PISSN: 1721727X     EISSN: 20587392     Source Type: Journal    
DOI: 10.1177/1721727X15619185     Document Type: Article

References (54)

1. Conese M and Assael BM (2001) Bacterial infections and inflammation in the lungs of cystic fibrosis patients. Pediatric Infectious Disease Journal 20: 207-213.
2. Ferrero-Miliani L, Nielsen OH, Andersen PS et al. (2007) Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1beta generation. Clinical and Experimental Immunology 147: 227-235.
3. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
4. Hume DA, Underhill DM, Sweet MJ et al. (2001) Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunology 2: 11.
5. Medzhitov R, Preston-Hurlburt P and Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388: 394-397.
6. Hemmi H, Takeuchi O, Kawai T et al. (2000) A Tolllike receptor recognizes bacterial DNA. Nature 408: 740-745.
7. Zhang D, Zhang G, Hayden MS et al. (2004) A tolllike receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526.
8. O'Neill LA (2008) 'Fine tuning' TLR signaling. Nature Immunology 9: 459-461.
9. Zhang FX, Kirschning CJ, Mancinelli R et al. (1999) Bacterial lipopolysaccharide activates nuclear factorkappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. Journal of Biological Chemistry 274: 7611-7614.
10. Rhee SH and Hwang D (2000) Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. Journal of Biological Chemistry 275: 34035-34040.
11. Lee JS, Nauseef WM, Moeenrezakhanlou A et al. (2007) Monocyte p110alpha phosphatidylinositol 3-kinase regulates phagocytosis, the phagocyte oxidase, and cytokine production. Journal of Leukocyte Biology 81: 1548-1561.
12. Guha M and Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. Journal of Biological Chemistry 277: 32124-32132.
13. Martin M, Schifferle RE, Cuesta N et al. (2003) Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. Journal of Immunology 171: 717-725.
14. Martin M, Rehani K, Jope RS et al. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature Immunology 6: 777-784.
15. Li X, Tupper JC, Bannerman DD et al. (2003) Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infection and Immunity 71: 4414-44120.
16. Deng L, Wang C, Spencer E et al. (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
17. Liang Y, Zhou Y and Shen P (2004) NF-kappaB and its regulation on the immune system. Cellular & Molecular Immunology 1: 343-350.
18. Li Q and Verma IM (2002) NF-kappaB regulation in the immune system. Nature Reviews Immunology 2: 725-734.
19. Doyle SL and O'Neill LA (2006) Toll-like receptors: From the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochemical Pharmacology 72: 1102-1113.
20. Kawai T, Adachi O, Ogawa T et al. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
21. O'Neill LA and Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology 7: 353-364.
22. Janssens S and Beyaert R (2003) Functional diversity and regulation of different interleukin-1 receptorassociated kinase (IRAK) family members. Molecular Cell 11: 293-302.
23. Dang PM, Fontayne A, Hakim J et al. (2001) Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. Journal of Immunology 166: 1206-1213.
24. Ivaska J, Bosca L and Parker PJ (2003) PKCepsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1. Nature Cell Biology 5: 363-369.
25. Fukao T, Yamada T, Tanabe M et al. (2002) Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nature Immunology 3: 295-304.
26. Han JM, Jin YY, Kim HY et al. (2010) Lavandulyl flavonoids from Sophora flavescens suppress lipopolysaccharide- induced activation of nuclear factorkappaB and mitogen-activated protein kinases in RAW264.7 cells. Biological & Pharmaceutical Bulletin 33: 1019-1023.
27. Kim JK and Park GM (2012) Indirubin-3-monoxime exhibits anti-inflammatory properties by downregulating NF-kappaB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells. Inflammation Research 61: 319-325.
28. Kaminska B, Gozdz A, Zawadzka M et al. (2009) MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anatomical Record 292: 1902-1913.
29. Kaminska B (2005) MAPK signalling pathways as molecular targets for anti-inflammatory therapy- from molecular mechanisms to therapeutic benefits. Biochimica Biophysica Acta 1754: 253-262.
30. Dey N, Liu T, Garofalo RP et al. (2011) TAK1 regulates NF-KappaB and AP-1 activation in airway epithelial cells following RSV infection. Virology 418: 93-101.
31. Wang R, Zhang M, Zhou W et al. (2011) NF-kappaB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression. Journal of Neurochemistry 116: 1160-1170.
32. Karin M and Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annual Review of Immunology 18: 621-663.
33. Kagan JC and Medzhitov R (2006) Phosphoinositidemediated adaptor recruitment controls Toll-like receptor signaling. Cell 125: 943-955.
34. Sweet MJ and Hume DA (1996) Endotoxin signal transduction in macrophages. Journal of Leukocyte Biology 60: 8-26.
35. Yoon HJ, Moon ME, Park HS et al. (2007) Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochemical and Biophysical Research Community 358: 954-959.
36. Xie C, Kang J, Li Z et al. (2012) The acai flavonoid velutin is a potent anti-inflammatory agent: Blockade of LPS-mediated TNF-alpha and IL-6 production through inhibiting NF-kappaB activation and MAPK pathway. Journal of Nutritional Biochemistry 23: 1184-1191.
37. Kim DH, Cho IH, Kim HS et al. (2006) Antiinflammatory effects of 8-hydroxydeoxyguanosine in LPS-induced microglia activation: Suppression of STAT3-mediated intercellular adhesion molecule-1 expression. Experimental & Molecular Medicine 38: 417-427.
38. Locksley RM, Killeen N and Lenardo MJ (2001) The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104: 487-501.
39. Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263.
40. Tobias PS and Curtiss LK (2007) Toll-like receptors in atherosclerosis. Biochemcial Society Transactions 35: 1453-1455.
41. Devaraj S, Dasu MR, Rockwood J et al. (2008) Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state. Journal of Clinical Endocrinology and Metabolism 93: 578-583.
42. Uematsu S and Akira S (2006) Toll-like receptors and innate immunity. Journal of Molecular Medicine (Berlin) 84: 712-725.
43. Parker PJ and Murray-Rust J (2004) PKC at a glance. Journal of Cell Science 117: 131-132.
44. Spitaler M and Cantrell DA (2004) Protein kinase C and beyond. Nature Immunology 5: 785-790.
45. Ojaniemi M, Glumoff V, Harju K et al. (2003) Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. European Journal of Immunology 33: 597-605.
46. la Sala A, Gadina M and Kelsall BL (2005) G(i)- protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. Journal of Immunology 175: 2994-2949.
47. Chi H, Barry SP, Roth RJ et al. (2006) Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 103: 2274-2279.
48. Chan ED and Riches DW (2001) IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. American Journal of Physiology Cell Physiology 280: C441-450.
49. Luo J, Xu Y, Zhang M et al. (2013) Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells: Magnolol inhibits LPS-induced inflammatory response. Inflammation 36: 997-1003.
50. Baker RG, Hayden MS and Ghosh S (2011) NF-kappaB, inflammation, and metabolic disease. Cell Metabolism 13: 11-22.
51. Lee YH, Jeon SH, Kim SH et al. (2012) A new synthetic chalcone derivative, 2-hydroxy-3',5,5'-trimethoxychalcone (DK-139), suppresses the Toll-like receptor 4-mediated inflammatory response through inhibition of the Akt/NF-kappaB pathway in BV2 microglial cells. Experimental & Molecular Medicine 44: 369-377.
52. Kim BH, Roh E, Lee HY et al. (2008) Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-kappaB activation and nuclear factor-kappaB- regulated gene transcription through inactivating inhibitory kappaB kinase beta. Molecular Pharmacology 73: 1309-1318.
53. Stoll LL, Denning GM, Li WG et al. (2004) Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: Expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. Journal of Immunology 173: 1336-1343.
54. Faure E, Equils O, Sieling PA et al. (2000) Bacterial lipopolysaccharide activates NF-kappaB through tolllike receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. Journal of Biological Chemistry 275: 11058-11063.